Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness

Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related death. Therapeutic options remain very limited and are based on classical chemotherapies. Energy metabolism reprogramming appears as an emerging hallmark of cancer and is considered a therapeutic target with conside...

Descripción completa

Detalles Bibliográficos
Autores principales: Rademaker, Gilles, Hennequière, Vincent, Brohée, Laura, Nokin, Marie-Julie, Lovinfosse, Pierre, Durieux, Florence, Gofflot, Stéphanie, Bellier, Justine, Costanza, Brunella, Herfs, Michael, Peiffer, Raphael, Bettendorff, Lucien, Deroanne, Christophe, Thiry, Marc, Delvenne, Philippe, Hustinx, Roland, Bellahcène, Akeila, Castronovo, Vincent, Peulen, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085282/
https://www.ncbi.nlm.nih.gov/pubmed/29720728
http://dx.doi.org/10.1038/s41388-018-0287-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085282/
https://www.ncbi.nlm.nih.gov/pubmed/29720728
http://dx.doi.org/10.1038/s41388-018-0287-z

Ejemplares similares